|1.||Navasa, Miquel: 1 article (07/2014)|
|2.||Martí, Josep: 1 article (07/2014)|
|3.||Fondevila, Constantino: 1 article (07/2014)|
|4.||García-Valdecasas, Juan Carlos: 1 article (07/2014)|
|5.||Crespo, Gonzalo: 1 article (07/2014)|
|6.||De la Serna, Sofia: 1 article (07/2014)|
|7.||Forns, Xavier: 1 article (07/2014)|
|8.||Ferrer, Joana: 1 article (07/2014)|
|9.||Fuster, Josep: 1 article (07/2014)|
|10.||Kositamongkol, Prawat: 1 article (09/2011)|
|1.||End Stage Liver Disease
09/01/2011 - "Eight risk factors predictive for GF after ReLT included recipient age greater than 55 years, Model for End-Stage Liver Disease score greater than 27, history of prior OLT greater than 1, pre-ReLT requirement for mechanical ventilation, serum albumin less than 2.5 g/dL, donor age greater than 45 years, intraoperative requirement of packed red blood cell transfusion greater than 30 units, and performance of ReLT between 15 and 180 days from the prior OLT. "
07/01/2014 - "Early severe HCV infection rate was similar in both groups, but it affected prognosis in ReLT more markedly than in LT (three-yr graft survival: 0% vs. 66.7%, p = 0.003). "
07/01/2014 - "ReLT patients showed a trend toward worse graft survival compared with LT (five-yr graft survival: 42.3% vs. 64.3%, p = 0.145), but the rate of severe HCV recurrence and infection-free survival (IFS) was similar. "
07/01/2014 - "Case-control analysis between patients undergoing ReLT for HCV reinfection between 1993 and 2012 (ReLT group: 26 patients) and patients undergoing liver transplantation (LT) for HCV infection immediately before and after each ReLT (LT group: 52 patients). "
|2.||Insulin-Like Growth Factor Binding Protein 2
|4.||Messenger RNA (mRNA)
|5.||tacrolimus binding protein 4 (FKBP52)
|3.||Artificial Respiration (Mechanical Ventilation)